New findings on the effects of xylitol ingestion in dogs

Veterinary Medicine

Volumn 101, Issue 12, 2006, Pages 791-798

  Dunayer, Eric K ^a  

^a ASPCA ANIMAL POISON CONTROL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 33846592921     PISSN: 87507943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Cronin JR. Xylitol: a sweet for healthy teeth and more. Alternative Complementary Ther 2003;9:139-141.
2. Gare F. The sweet miracle of xylitol. North Bergan, NJ: Basic Health Publications Inc, 2003.
3. Lang KL. Utilization of xylitol in animals and man. In: Horecker BL, Lang K, Takagi Y. eds. International symposium on metabolism, physiology, and clinical use of pentoses and pentitols. New York: Springer-Verlag, 1969;151-157.
4. Dehmel KH, Förster H, Mehnert H. Absorption of xylitol. In: Horecker BL, Lang K, Takagi Y. eds. International symposium on metabolism, physiology, and clinical use of pentoses and pentitols. New York: Springer-Verlag, 1969;177-181.
5. Asano T, Levitt MD, Goetz FC. Xylitol absorption in healthy men. Diabetes 1973;22:279-281.
6. Kuzuya T, Kanazawa Y, Kosaka K. Stimulation of insulin secretion by xylitol in dogs. Endocrinology 1969;84:200-207.
7. Froesch ER, Jakob A. The metabolism of xylitol. In: Sipple HL, McNutt KW, eds. Sugars in nutrition. New York: Academic Press, 1974;241-258.
8. International Programme on Chemical Safety, World Health Organization. Summary of toxicological data of certain food additives: WHO food additives series no. 12: xylitol. Geneva, 1977. Available at: www.inchem.org/documents/ jecfa/jecmono/v12je22.htm. Accessed Nov 30, 2005.
9. Brin M, Miller ON. The safety of oral xylitol. In: Sipple HL, McNutt KW, eds. Sugars in nutrition. New York: Academic Press, 1974;591-606.
10. Kuzuya T, Kanazawa Y, Kosaka K. Plasma insulin response to intravenously administered xylitol in dogs. Metabolism 1966;15:1149-1152.
11. Hirata Y, Fujisawa M, Sato H, et al. Blood glucose and plasma insulin responses to xylitol administered intravenously in dogs. Biochem Biophys Res Commun 1966;24:471-475.
12. Dunayer EK, Gwaltney-Brant SM. Acute hepatic failure and coagulopathy associated with xylitol ingestion in eight dogs. J Am Vet Med Assoc 2006;229:1113-1117.
13. Dunayer EK. Hypoglycemia following canine ingestion of xylitol-containing gum. Vet Hum Toxicol 2004;46:87-88.
14. Nelson RW. Diabetes mellitus. In: Ertinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 6th ed. St. Louis, Mo: Elsevier Saunders, 2005;1563-1591.
15. Church D. Electrolyte disorders. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 6th ed. St. Louis, Mo: Elsevier Saunders, 2005;236-240.
16. Feldman EC. Disorders of the parathyroid gland. In: Ertinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 6th ed. St. Louis, Mo: Elsevier Saunders, 2005;1508-1535.
17. Kuzuya T, Kanazawa Y, Hayashi M, et al. Spedes difference in plasma insulin responses to intravenous xylitol in man and several mammals. Endocrinol Jpn 1971;18:309-320.
18. Jourdan MH, Macdonald I, Henderson JR. The effects of 14C xylitol, given intravenously on the serum-glucose, insulin, and lipid concentrations of male and female baboons. Nutr Metabol 1972;14:92-99.
19. Woods HF, Krebs HA. Xylitol metabolism in the isolated perfused rat liver. Biochem J 1973;134:437-443.
20. Vincent MF, Van den Berghe G, Hers HG. D-xylulose-induced depletion of ATP and Pi in isolated rat hepatocytes. FASEB J 1989;3:1855-1861.
21. Bailey SM, Cunningham CC. Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. Hepatology 1998;28:1318-1326.
22. U.S. Food and Drug Administration. Artificial sweeteners: no calories...sweet! FDA Consumer Magazine 2006 Available at: http://www.fda.gov/fdac/fearures/2006/406_sweeteners.html. Accessed Oct 31, 2006.
23. Nelson RW, Couto CG. Diseases of the endocrine pancreas. In: Small animal internal medicine. 3rd ed. St. Louis, Mo: Mosby, 2003;729-777.
24. Plumlee KH. Hepatobiliary system. In: Plumlee KH, ed. Clinical veterinary toxicology. St. Louis, Mo: Mosby, 2004;61-68.
25. Sherk MA, Center SA. Toxic, metabolic, infectious, and neoplastic liver diseases. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine: diseases of the dog and cat. 6th ed. St. Louis, Mo: Elsevier Saunders, 2005; 1464-1478.
26. Cope RB. A screening study of xylitol binding in vitro to activated charcoal. Vet Hum Toxicol 2004;46:336-337.